购物车
全部删除
您的购物车当前为空
别名 LAS-191351, LAS191351, LAS 191351, AZD-8871, AZD8871, AZD 8871
AZD-8871 can present a novel treatment approach to chronic obstructive pulmonary disease [COPD] and potentially also asthma (in combination with an inhaled corticosteroid [ICS]).

AZD-8871 can present a novel treatment approach to chronic obstructive pulmonary disease [COPD] and potentially also asthma (in combination with an inhaled corticosteroid [ICS]).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | 待询 | 3-6月 | |
| 50 mg | 待询 | 3-6月 | |
| 100 mg | 待询 | 3-6月 |
Navafenterol 相关产品
| 产品描述 | AZD-8871 can present a novel treatment approach to chronic obstructive pulmonary disease [COPD] and potentially also asthma (in combination with an inhaled corticosteroid [ICS]). |
| 别名 | LAS-191351, LAS191351, LAS 191351, AZD-8871, AZD8871, AZD 8871 |
| 分子量 | 742.91 |
| 分子式 | C38H42N6O6S2 |
| CAS No. | 1435519-06-4 |
| 密度 | 1.45 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容